Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
about
Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testingNoncoding RNA: Current Deep Sequencing Data Analysis Approaches and Challenges.Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicityIn-silico QTL mapping of postpubertal mammary ductal development in the mouse uncovers potential human breast cancer risk loci.Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.gDNA enrichment by a transposase-based technology for NGS analysis of the whole sequence of BRCA1, BRCA2, and 9 genes involved in DNA damage repair.microRNA editing in seed region aligns with cellular changes in hypoxic conditions.Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriersPolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathwaysrs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2.Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.MicroRNA‑103 regulates tumorigenesis in colorectal cancer by targeting ZO‑1.Identification of Single Nucleotide Non-coding Driver Mutations in Cancer.Functional SNP in 3'-UTR MicroRNA-Binding Site of ZNF350 Confers Risk for Age-Related Cataract.A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population
P2860
Q28652730-EDDBB6DB-32E6-4B4F-97BD-3E295CC8E4A9Q31121214-23ED1E15-7411-459F-BAF0-F1900B4A6772Q33700463-18E4B594-1FD5-4A62-9F08-B8E61E8EA1B1Q35994508-70A70A5A-FAA2-415E-AB7A-CAE49742A19AQ36322003-A8F96A6E-22D5-4FD8-A02B-5E1193590B8CQ36788376-B24EEB28-DA19-407D-A677-1E857693FBE6Q37197466-41CA922C-AAAE-4A39-BF79-50D42FEBD5A2Q37295507-E366A7A5-0741-4ADC-83C0-11575C8456B8Q38493900-15BE2E6B-819D-4676-9044-CDE9D544BA52Q38733762-39EA06A8-EFDA-4BD3-A3AB-BCAA0C541158Q38994908-B6E84524-44CA-46AC-8622-A536098FB267Q41691570-9F0C67D2-89DA-4CC4-A121-2B848EB38364Q43806776-2EE96B3E-C36C-441E-9678-01BF0590165BQ49776558-606ECAAD-B8AA-48B4-A813-F315307FC16AQ49884827-593E4FA8-AA61-4DC2-9897-883051AE37F9Q51537566-4DA2B24A-D998-4FE0-A40F-31A302EDDD40Q55425427-A3C8EAC8-8C38-4119-9AA3-E3A7E276C187
P2860
Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Identification of fifteen nove ...... unctional miR-103 target site.
@en
Identification of fifteen nove ...... unctional miR-103 target site.
@nl
type
label
Identification of fifteen nove ...... unctional miR-103 target site.
@en
Identification of fifteen nove ...... unctional miR-103 target site.
@nl
prefLabel
Identification of fifteen nove ...... unctional miR-103 target site.
@en
Identification of fifteen nove ...... unctional miR-103 target site.
@nl
P2093
P2860
P50
P356
P1433
P1476
Identification of fifteen nove ...... unctional miR-103 target site.
@en
P2093
Andrew K Godwin
Ania Wronski
Betsy Bove
Brooke L Brewster
Francesca Rossiello
Juliet D French
Loris Bernard
Monica Barile
P2860
P304
P356
10.1002/HUMU.22159
P50
P577
2012-08-02T00:00:00Z